155 related articles for article (PubMed ID: 10349613)
1. Experimental infusion phlebitis: tolerance pH of peripheral vein.
Kuwahara T; Asanami S; Kawauchi Y; Kubo S
J Toxicol Sci; 1999 May; 24(2):113-21. PubMed ID: 10349613
[TBL] [Abstract][Full Text] [Related]
2. Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition.
Kuwahara T; Asanami S; Tamura T; Kaneda S
J Toxicol Sci; 1998 Feb; 23(1):77-85. PubMed ID: 9513923
[TBL] [Abstract][Full Text] [Related]
3. Experimental infusion phlebitis: importance of titratable acidity on phlebitic potential of infusion solution.
Kuwahara T; Asanami S; Tamura T; Kubo S
Clin Nutr; 1996 Jun; 15(3):129-32. PubMed ID: 16844015
[TBL] [Abstract][Full Text] [Related]
4. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells.
Kuwahara T; Asanami S; Kubo S
Nutrition; 1998 Jun; 14(6):496-501. PubMed ID: 9646289
[TBL] [Abstract][Full Text] [Related]
5. Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits.
Kohno E; Murase S; Matsuyama K; Okamura N
Int J Med Sci; 2009 Aug; 6(5):218-23. PubMed ID: 19680474
[TBL] [Abstract][Full Text] [Related]
6. Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits.
Kohno E; Murase S; Nishikata M; Okamura N; Matzno S; Kuwahara T; Matsuyama K
Int J Med Sci; 2008 Jul; 5(4):218-23. PubMed ID: 18695742
[TBL] [Abstract][Full Text] [Related]
7. Dilution is effective in reducing infusion phlebitis in peripheral parenteral nutrition: an experimental study in rabbits.
Kuwahara T; Asanami S; Tamura T; Kubo S
Nutrition; 1998 Feb; 14(2):186-90. PubMed ID: 9530646
[TBL] [Abstract][Full Text] [Related]
8. Toxicological study of a glucose-added acetic acid maintenance infusion solution (VEEN 3G Inj.) local irritation test.
Onodera K; Kawaguch M; Shibata M; Kagawa M; Kojima J; Shimizu K; Yoneko M; Wachi M
Drugs Exp Clin Res; 2002; 28(1):17-25. PubMed ID: 12073764
[TBL] [Abstract][Full Text] [Related]
9. Considerations on prevention of phlebitis and venous pain from intravenous prostaglandin E(1) administration by adjusting solution pH: in vitro manipulations affecting pH.
Kohno E; Nishikata M; Okamura N; Matsuyama K
Yakugaku Zasshi; 2008 Jan; 128(1):111-5. PubMed ID: 18176061
[TBL] [Abstract][Full Text] [Related]
10. Peripheral vein complications in patients receiving amino acid/dextrose solutions.
Massar EL; Daly JM; Copeland EM; Johnson DE; VonEshenbach AC; Johnston D; Rundell B; Dudrick SJ
JPEN J Parenter Enteral Nutr; 1983; 7(2):159-62. PubMed ID: 6406705
[TBL] [Abstract][Full Text] [Related]
11. Factors determining peripheral vein tolerance to amino acid infusions.
Gazitua R; Wilson K; Bistrian BR; Blackburn GL
Arch Surg; 1979 Aug; 114(8):897-900. PubMed ID: 111645
[TBL] [Abstract][Full Text] [Related]
12. [Etiology and management of venous pain during intravenous administration of oxaliplatin].
Matsuyama K; Mishima H; Ueno H; Kajihara K; Morioka A; Morimoto S; Yamauchi K; Honda Y; Komori K; Tsujinaka T
Gan To Kagaku Ryoho; 2011 Mar; 38(3):411-4. PubMed ID: 21403443
[TBL] [Abstract][Full Text] [Related]
13. Experimental research on preventing mechanical phlebitis arising from indwelling needles in intravenous therapy by external application of mirabilite.
Lu Y; Hao C; He W; Tang C; Shao Z
Exp Ther Med; 2018 Jan; 15(1):276-282. PubMed ID: 29250150
[TBL] [Abstract][Full Text] [Related]
14. The intervention research on treatment by Xianchen to rabbits model of chemotherapeutic phlebitis.
Zhang J; Shen J; Yin W; Wei X; Wu L; Liu H
Acta Cir Bras; 2016 Aug; 31(8):549-56. PubMed ID: 27579883
[TBL] [Abstract][Full Text] [Related]
15. Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
Powis G; Kovach JS
Cancer Res; 1983 Feb; 43(2):925-9. PubMed ID: 6848203
[TBL] [Abstract][Full Text] [Related]
16. Peripheral vein infusion of dextrose/amino acid solutions +/- 20% fat emulsion.
Daly JM; Masser E; Hansen L; Canham JE
JPEN J Parenter Enteral Nutr; 1985; 9(3):296-9. PubMed ID: 4009919
[TBL] [Abstract][Full Text] [Related]
17. The use of lipid emulsions for the i.v. administration of a new water soluble polyene antibiotic, SPK-843.
Mozzi G; Benelli P; Bruzzese T; Galmozzi MR; Bonabello A
J Antimicrob Chemother; 2002 Feb; 49(2):321-5. PubMed ID: 11815574
[TBL] [Abstract][Full Text] [Related]
18. Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.
Lanbeck P; Odenholt I; Riesbeck K
J Antimicrob Chemother; 2004 Feb; 53(2):174-9. PubMed ID: 14729754
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of prostaglandin E1 intravenous solution reduces infusion phlebitis.
Fujita M; Hatori N; Shimizu M; Yoshizu H; Segawa D; Kimura T; Iizuka Y; Tanaka S
Angiology; 2000 Sep; 51(9):719-23. PubMed ID: 10999612
[TBL] [Abstract][Full Text] [Related]
20. Studies in phlebitis VIII: evaluations of pH solubilized intravenous dexverapamil formulations.
Simamora P; Pinsuwan S; Surakitbanharn Y; Yalkowsky SH
PDA J Pharm Sci Technol; 1996; 50(2):123-8. PubMed ID: 8935779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
